(MedPage Today) — Under a program designed to accelerate the approval of products that could address key national priorities, the FDA awarded a national priority voucher to teclistamab (Tecvayli) in combination with daratumumab (Darzalex) for…
Source link : https://www.medpagetoday.com/hematologyoncology/myeloma/119018
Author :
Publish date : 2025-12-15 19:23:00
Copyright for syndicated content belongs to the linked Source.
